[translate] aFor honest I kinda horny 为诚实的I有点儿有角 [translate] aPlatinum-based chemotherapy in triple-negative breast cancer: A meta-analysis. 基于白金的化疗在三倍消极乳腺癌: 阶分析。 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语...
化疗反应分析用试样测试和预测为接受了anthracycline-并且基于taxane化疗的乳腺癌患者。 [translate] a[Platinum-based chemotherapy in triple negative breast cancer]. (基于白金的化疗在三倍消极乳腺癌)。 [translate] 英语翻译 日语翻译 韩语翻译 德语翻译 法语翻译 俄语翻译 阿拉伯语翻译 西班牙语翻译 葡萄牙语翻译 ...
中文文献 专利 1. Hearing impairment after platinum-based chemotherapy in childhood. [J] . Einar Jon E, Trausti O, Asgeir H, Pediatric blood & cancer . 2011,第4期 机译:儿童铂类化学疗法后出现听力障碍。 2. ASSOCIATION OF HEARING LOSS WITH COGNITIVE AND EMOTIONAL FUNCTIONING IN NON- CNS TU...
[Platinum-based chemotherapy in triple negative breast cancer].5个回答 [在三阴性乳腺癌铂为基础的化疗。2013-05-23 12:21:38 回答:匿名 [在三倍消极乳腺癌的基于白金的化疗]。 2013-05-23 12:23:18 回答:匿名(基于白金的化疗在三倍消极乳腺癌)。 2013-05-23 12:24:58 回答:匿名[基于铂化疗在三...
askype skype?[translate] ashow that Asian patients also derived benefit from maintenance therapy with erlotinib after first-line, platinum-based chemotherapy. 表示,亚裔患者从维护疗法也获得了好处与erlotinib在最重要,基于白金的化疗以后。[translate]...
aThe findings of this preplanned subanalysis show that Asian patients also derived benefit from maintenance therapy with erlotinib after first-line, platinum-based chemotherapy. 亚洲病人也得到的这次被预先计划的子分析显示的调查结果利用 erlotinib 获益于维护疗法在第一线,基于白金的化疗之后。 [translate] ...
aherp day cleanaing cream herp天cleanaing的奶油[translate] aFGFR2 gene fusions or other FGFR genetic alterations who failed or are intolerant to platinum-based chemotherapy FGFR2基因融合或其他FGFR基因改变不合格或是不宽容的到基于白金的化疗[translate]...
您在几乎那里-请检查您的inbox电子邮件从我们核实您的帐户! [translate] aInvestigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression. 正在翻译,请等待... [translate] ...
atrials in over 1000 patients conducted in first-line patients with locally advanced or metastatic NSCLC showed no clinical benefit with the concurrent administration of TARCEVA with platinum-based chemotherapy 试验完全成功在最重要的患者举办的1000名患者与当地先进的或变形的NSCLC没有显示临床好处与TARCEVA的...
aThe primary objective of the study was to determine if the administration of TARCEVA after standard platinum-based chemotherapy in the treatment of NSCLC resulted in improved progression free survival (PFS) when compared with placebo, in all patients or in patients with EGFR immunohistochemistry (IHC...